Back

Mortality in patients with non-valvular atrial fibrillation in South America. Warfarin has significant higher global mortality rates versus dabigatran and rivaroxaban

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 4 Heart Teams for Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Gabriel Vanerio

CASMU Arrhythmia Center & British Hospital, Montevideo (Uruguay)

8 More presentations in this session

Presentation thumbnail
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Professor J. Hartikainen (Kuopio, FI)
Abstract Slides
Presentation thumbnail
Associate Professor S. Choi (Daegu, KR)
Abstract Slides
Presentation thumbnail
Professor C. Coleman (Storrs, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 4

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources